REFERENCES
- Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Path 1995; 19: 1409–17.
- Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F. Histologic grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696–9.
- Mattsson L, Grillner L, Weiland O. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test. Scand J Infect Dis 1992; 24: 15–20.
- Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 1999; 116: 378–86.
- Poynard T, Bedossa P, Opolon P, for the OBSVIRC M, CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825–32.
- Weiland O, Norkrans G, Frydén A, Braconier J. Hälften svarar på interferonbehandling. Kombinationsterapi alternativ vid kronisk hepatit C. Läkartidningen 1995; 92: 1920–2.
- Weiland O, Danielsson Å, Lööf L. Mängden virus i serum avgörande för resultatet. Läkartidningen 1998; 95: 40–3.
- Reichard O, Norkrans G, Frydén A, Braconier J, Sönnerborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alfa-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351: 83–7.
- Poynard T, Marcelin P, Lee S, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon alfa-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426–32.
- McHutchison J, Gordon S, Schiff E, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485–92.
- Weiland O. Treatment of naive patients with hepatitis C. J Hepatology 1999; 31: 168–73.
- Davis GL, Esteban Muir R, Rustgi V, Hoefs J, Gordon SC, Trepo C, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 1493–9.
- Schalm S, Hansen B, Chemello L, Bellobuono A, Brouwer JT, Weiland O, et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: a metaanalysis of individual patient data from European centers. J Hepatol 1997; 26: 961–6.
- Schalm S, Weiland O, Hansen B, Milella M, Lai ML, Hollander A, et al. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled studies. Eurohep Study Group for Viral Hepatitis. Gastroenterol 1999; 117: 408–13.
- Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison. Hepatology 1997; 26: 1640–5.
- Brouwer JT, Hansen BE, Niesters HGM, Schalm SW. Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. J Hepatol 1999; 30: 192–8.
- Thomas SL, Newell M-L, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with or without HCV viraemia or human immunodeficiency virus infection. Int J Epidem 1998; 27: 108–17.
- Bortolotti F, Vajro P, Cadrobbi P, Lepore L, Zancan L, Barbera C, et al. Cryptogenic chronic liver disease and hepatitis C virus infection in children. J Hepatol 1992; 15: 73–6.
- Bernard O. Mother-to-infant transmission of hepatitis C. Acta Gastroenterol Belg 1998; 61: 192–4.
- Kage M, Fujisawa T, Shiraki K. Pathology of chronic hepatitis C in children. Hepatology 1997; 26: 771–5.
- Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, et al. Recombinant interferon-alpha therapy in children with chronic hepatitis C. Hepatology 1995; 22: 1623–7.
- Sawada A, Tajiri H, Kozaiwa K, Guo W, Tada K, Etani Y, et al. Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C. J Hepatol 1998; 28: 184–8.
- Jonas MM, Ott MJ, Nelson SP, Badizegan K, Perez-Atayde AR. Interferon-alpha treatment of chronic hepatitis C virus infection in children. Pediatr Infect Dis J 1998; 17: 241–6.
- Neumann A, Lam N, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alfa therapy. Science 1998; 282: 103–7.